| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/06/2006 | EP1697516A2 Maize metallothionein promoter |
| 09/06/2006 | EP1697508A2 Crystal structure of interleukin-2 tyrosine kinase (itk) and binding pockets thereof |
| 09/06/2006 | EP1697507A1 Use of proteins and peptides coded by the genome of a novel strain of sars-associated coronavirus |
| 09/06/2006 | EP1697504A1 Use of il-6-type cytokines for maturation of oocytes |
| 09/06/2006 | EP1697497A2 Liver cancer biomarkers |
| 09/06/2006 | EP1697420A2 Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention |
| 09/06/2006 | EP1697418A2 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation |
| 09/06/2006 | EP1697414A2 Process for the production of tumor necrosis factor-binding proteins |
| 09/06/2006 | EP1697413A2 Human lxr alpha variants |
| 09/06/2006 | EP1697412A1 Method for purifying fsh |
| 09/06/2006 | EP1697411A1 Process for purifying interferon beta |
| 09/06/2006 | EP1697410A1 Isolated cytotoxic factor associated with multiple sclerosis and method of detecting said cytotoxic factor |
| 09/06/2006 | EP1697409A1 Secreted neural apoptosis inhibiting proteins |
| 09/06/2006 | EP1697408A2 Tumor antigens, and use thereof |
| 09/06/2006 | EP1697407A2 Regulation involving abin-2 |
| 09/06/2006 | EP1697406A1 Protein separation device |
| 09/06/2006 | EP1697405A1 Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 09/06/2006 | EP1697404A2 Cc-chemokine binding tick proteins |
| 09/06/2006 | EP1697403A2 Haemophilus influenzae type iv pili |
| 09/06/2006 | EP1697402A2 Gene variants coding for proteins from the metabolic pathway of fine chemicals |
| 09/06/2006 | EP1697399A2 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 |
| 09/06/2006 | EP1696964A1 Use of microparticles for antigen delivery |
| 09/06/2006 | EP1696963A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 09/06/2006 | EP1696962A2 Novel glp-1 analogues linked to albumin-like agents |
| 09/06/2006 | EP1696953A1 Recombinant vibrio cholerae strain and vaccine comprising said strain |
| 09/06/2006 | EP1696952A1 Anti-retroviral agents, compositions, methods and uses |
| 09/06/2006 | EP1696950A2 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its use for the treatment of angiogenic-related disorders |
| 09/06/2006 | EP1696949A2 Vegf receptor antagonists |
| 09/06/2006 | EP1696945A1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 09/06/2006 | EP1696944A2 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 09/06/2006 | EP1696943A2 Diastereomeric peptides useful as inhibitors of membrane protein assembly |
| 09/06/2006 | EP1696916A1 Use of metabotropic glutamate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders |
| 09/06/2006 | EP1563075A4 Plasmids expressing human insulin and the preparation method for human insuling thereby |
| 09/06/2006 | EP1546185A4 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
| 09/06/2006 | EP1356054B1 Bacillus thuringiensis proteins and vatiants thereof with pesticidal activity against coleopterans |
| 09/06/2006 | EP1282642B1 Therapeutic pore-forming peptides |
| 09/06/2006 | EP1243595B1 Bh4-fused polypeptides |
| 09/06/2006 | EP1214350B1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 09/06/2006 | EP1198476B1 Death effector domain of mammalian apoptosis mediator, fadd, inducing bacterial cell death |
| 09/06/2006 | EP1131081A4 Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signaling pathway |
| 09/06/2006 | EP1127149B1 Cells for the production of helper dependent adenoviral vectors |
| 09/06/2006 | EP1088075B1 Aav structural protein, production and use thereof |
| 09/06/2006 | EP1071449B1 Use of an antagonist antibody to the inflammatory mediator oncostatin m (osm) |
| 09/06/2006 | EP1027373B1 Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression |
| 09/06/2006 | EP0955366B1 Antigenic protein originating in malassezia |
| 09/06/2006 | EP0914341B1 Antagonists of intestinotrophic glp-2 peptides |
| 09/06/2006 | EP0832232B9 Kunitz type plasma kallikrein inhibitors |
| 09/06/2006 | EP0789762B1 Methods for the diagnosis of glaucoma |
| 09/06/2006 | EP0760857B9 Receptor for oncostatin m |
| 09/06/2006 | CN1829796A Novel full-length genomic rna of Japanese encephalitis virus, infectious jev cDNA therefrom, and use thereof |
| 09/06/2006 | CN1829739A Crystalline tumor necrosis factor receptor 2 polypeptides |
| 09/06/2006 | CN1829738A Novel insulin derivatives |
| 09/06/2006 | CN1829737A Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family |
| 09/06/2006 | CN1829732A Imageable animal model of SARS infection |
| 09/06/2006 | CN1829727A High viscosity xanthan polymer preparations |
| 09/06/2006 | CN1829526A Soluble CLCA-1 and antagonists to CLCA-1 |
| 09/06/2006 | CN1827767A Metallothionein-like protein gene of Tamarix androssowii Litw. |
| 09/06/2006 | CN1827646A Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/06/2006 | CN1827645A Lomefloxacin conjugate and its preparing method and use |
| 09/06/2006 | CN1827644A Pefloxacin couple and its preparing method and use |
| 09/06/2006 | CN1827643A Danofloxacin couple and its preparing method and use |
| 09/06/2006 | CN1827642A Ofloxacin couple and its preparing method and use |
| 09/06/2006 | CN1827641A Antimicrobial polypeptide from Amolops loloensis and its pharmaceutical use |
| 09/06/2006 | CN1827640A Polypeptide for inhibition of angiogenesis and method for preparing same and use thereof |
| 09/06/2006 | CN1827639A 新的细胞因子zalpha11配体 New cytokine zalpha11 Ligand |
| 09/06/2006 | CN1273614C Synaptic knob association membrane protein 25 and its use |
| 09/06/2006 | CN1273605C 蛋白质生产系统 Protein Production System |
| 09/06/2006 | CN1273602C Recombinant monellin suitable to express in yeast and method for preparing same |
| 09/06/2006 | CN1273600C Chinese yew tarad-ane C13-lateral chain-N-benzoyl transiting enzymic protein and its coding gene |
| 09/06/2006 | CN1273598C Bactericidal/permeability-increasing protein delation analogs |
| 09/06/2006 | CN1273597C Fusion osmotic pressure regulating gent and protein their preparation process and application |
| 09/06/2006 | CN1273596C Meiosis gene of paddy, coding protein and application |
| 09/06/2006 | CN1273594C Method, special plasmid and function nucleotide segment for obtaining male sterile wheat |
| 09/06/2006 | CN1273487C Collagen and method for preparing collagen from skins of birds |
| 09/06/2006 | CN1273486C Tumour specific antigen TA48 and its application in cancer diagnosis |
| 09/06/2006 | CN1273485C Immunoglobulin sample receptor originated from human dendritic cell, its coding sequence and application |
| 09/06/2006 | CN1273484C Purifying method for recombination human leukopenic-1 receptor antagonist |
| 09/06/2006 | CN1273483C bZIP transcription factor of corn and its encoding genes and use |
| 09/06/2006 | CN1273482C Hepatitis C virus tunic protein E2 gene capable of being total length expressed in E. coli, its coding protein and use |
| 09/05/2006 | USRE39270 infecting insect larvae with a baculovirus vector of a DNA encoding the protein of interest linked to a gene encoding a green fluorescent protein; fusion protein is expressed; measuring GFT fluorescence |
| 09/05/2006 | US7102059 Isolated nucleic acid molecule containing one open reading frame; a nucleotide sequence, or a complementary sequence encoding proteins or polypeptides of Pseudomonas CEL and EEL genomic regions or hybridizes to a DNA molecule |
| 09/05/2006 | US7102058 Phytic acid biosynthetic enzymes |
| 09/05/2006 | US7102024 Functional biopolymer modification reagents and uses thereof |
| 09/05/2006 | US7101990 Bax-responsive genes for drug target identification in yeast and fungi |
| 09/05/2006 | US7101988 Polyvalent cation-sensing receptor in Atlantic salmon |
| 09/05/2006 | US7101987 For controlling development, differentiation, trafficking, and physiology of mammalian cells; diagnosis |
| 09/05/2006 | US7101985 Methods and compositions in checkpoint signaling |
| 09/05/2006 | US7101984 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/05/2006 | US7101982 Using buffer mixture; genetic engineered proteins |
| 09/05/2006 | US7101981 Bovine growth hormone recombinantly produced in E. coli |
| 09/05/2006 | US7101980 Derivatives, conjugates, and antibodies for detecting ecstasy-class analytes |
| 09/05/2006 | US7101979 Antibodies to antiangiogenic compositions and methods |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 09/05/2006 | US7101973 β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 09/05/2006 | US7101972 With binding specificity for target nucleotides containing one or GNN triplets; regulating gene expression |
| 09/05/2006 | US7101971 Erythropoietin analog-human serum albumin fusion |
| 09/05/2006 | US7101970 PRO1570 polypeptides |
| 09/05/2006 | US7101969 Inhibiting bacterial growth by contacting bacteria in vitro with an amino acid sequence phage open reading frame product interacts with amino acids of S. aureus DnaI polypeptide; interaction target site as the basis of drug screening assays |
| 09/05/2006 | US7101968 One-step reduction and alkylation of proteins |